123 related articles for article (PubMed ID: 7717384)
1. Hairy cell leukemia: treatment results and association with secondary malignancy.
Kwong YL; Liang R; Chiu E; Chan DW; Chan TK
Am J Hematol; 1995 Apr; 48(4):291. PubMed ID: 7717384
[No Abstract] [Full Text] [Related]
2. Secondary acute myeloid leukemia 4 years after the diagnosis of hairy cell leukemia: case report and review of the literature.
Al-Fiar F; Meharchand J; Curtis J; Lipton JH
Leuk Res; 1999 Aug; 23(8):719-21. PubMed ID: 10456669
[TBL] [Abstract][Full Text] [Related]
3. Observations on the development of T-cell leukaemia in the patient successfully treated by interferon-alpha for typical hairy cell leukaemia (HCL).
Demeter J; Paloczi K
Leukemia; 1992 Nov; 6(11):1235-6. PubMed ID: 1290544
[No Abstract] [Full Text] [Related]
4. Hairy cell leukemia: treatment successes in the past 25 years.
Golomb HM
J Clin Oncol; 2008 Jun; 26(16):2607-9. PubMed ID: 18509168
[No Abstract] [Full Text] [Related]
5. [Hairy cell leukemia and its treatment with 2-chlorodeoxyadenosine (2-CdA)].
Pawelski S
Acta Haematol Pol; 1995; 26(2):139-43. PubMed ID: 7653218
[TBL] [Abstract][Full Text] [Related]
6. Cladribine (2-chlorodeoxyadenosine) therapy in hairy cell leukemia variant. A report of three cases.
Palomera L; Domingo JM; Sola C; Azaceta G; Calvo MT; Gutierrez M
Haematologica; 2002 Jan; 87(1):107-8. PubMed ID: 11801472
[No Abstract] [Full Text] [Related]
7. Secondary acute myeloid leukemia following successful treatment of hairy cell leukemia with cladribine.
Seshadri P
Leuk Res; 2000 Jul; 24(7):637. PubMed ID: 10979762
[No Abstract] [Full Text] [Related]
8. Do we know the treatment of choice for hairy cell leukemia?
Golomb HM
Ann Oncol; 1994 Oct; 5(8):676-7. PubMed ID: 7826898
[No Abstract] [Full Text] [Related]
9. Secondary T-lymphoblastic leukemia in a patient with hairy cell leukemia following cladribine therapy: report of an extremely rare case and review of the literature.
Setoodeh R; Zhang L
Leuk Lymphoma; 2012 Apr; 53(4):736-8. PubMed ID: 21980957
[No Abstract] [Full Text] [Related]
10. Epstein-Barr virus-associated B-cell non-Hodgkin lymphoma following treatment of hairy cell leukemia with cladribine.
Lenz G; Golf A; Rüdiger T; Hiddemann W; Haferlach T
Blood; 2003 Nov; 102(9):3457-8. PubMed ID: 14568909
[No Abstract] [Full Text] [Related]
11. Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study.
Johnston JB; Eisenhauer E; Wainman N; Corbett WE; Zaentz SD; Daeninck PJ
Semin Oncol; 2000 Apr; 27(2 Suppl 5):32-6. PubMed ID: 10877049
[TBL] [Abstract][Full Text] [Related]
12. Hairy cell leukemia in father and son.
Cetiner M; Adigüzel C; Argon D; Ratip S; Eksioglu-Demiralp E; Tecimer T; Bayik M
Med Oncol; 2003; 20(4):375-8. PubMed ID: 14716034
[TBL] [Abstract][Full Text] [Related]
13. [Alpha interferon treatment in hairy cell leukemia].
Hagberg H
Nord Med; 1992; 107(3):74-5. PubMed ID: 1347920
[TBL] [Abstract][Full Text] [Related]
14. Hairy-cell leukaemia: first-line treatment with cladribine or pentostatin.
Prescrire Int; 2006 Aug; 15(84):143-4. PubMed ID: 16989031
[TBL] [Abstract][Full Text] [Related]
15. An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine.
Jehn U; Bartl R; Dietzfelbinger H; Haferlach T; Heinemann V
Leukemia; 2004 Sep; 18(9):1476-81. PubMed ID: 15229616
[TBL] [Abstract][Full Text] [Related]
16. Second cancer risk in hairy cell leukemia: analysis of 350 patients.
Kurzrock R; Strom SS; Estey E; O'Brien S; Keating MJ; Jiang H; Adams T; Talpaz M
J Clin Oncol; 1997 May; 15(5):1803-10. PubMed ID: 9164188
[TBL] [Abstract][Full Text] [Related]
17. Risk of additional cancers in untreated and treated hairy cell leukemia patients.
Dasanu CA; Alexandrescu DT
Expert Opin Pharmacother; 2010 Jan; 11(1):41-50. PubMed ID: 20001428
[TBL] [Abstract][Full Text] [Related]
18. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine).
Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K
Wien Klin Wochenschr; 1999 Dec; 111(24):1027-30. PubMed ID: 10677889
[TBL] [Abstract][Full Text] [Related]
19. Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment.
Bastie JN; Cazals-Hatem D; Daniel MT; D'Agay MF; Rabian C; Glaisner S; Noel-Walter MP; Dabout D; Flandrin G; Dombret H; Poisson D; Degos L; Castaigne S
Leuk Lymphoma; 1999 Nov; 35(5-6):555-65. PubMed ID: 10609793
[TBL] [Abstract][Full Text] [Related]
20. Optimal treatment for untreated patients with hairy cell leukemia?
Troussard X; Flandrin G
J Clin Oncol; 1995 Oct; 13(10):2677-9. PubMed ID: 7595722
[No Abstract] [Full Text] [Related]
[Next] [New Search]
